STRO
Sutro Biopharma Inc
Halal Rating :
Last Price
$2.02
Last updated:
Market Cap
-
7D Change
12.85%
1 Year Change
-54.71%
Company Overview
Industries
Exchange
Next Earnings Date
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company focuses on developing novel cancer therapeutics and antibody-drug conjugates (ADCs). Their proprietary technology platform, XpressCF®, enables the production of novel proteins and optimizes the drug discovery process.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $8.52m | $62.18m | - | $-14257000.0 | 0.00% | 22.93% |
| June 30, 2024 | $25.71m | $83.44m | - | $9.04m | 0.00% | 10.84% |
| March 31, 2024 | $13.01m | $79.0m | - | $9.4m | 0.00% | 11.90% |
Company Impact
Help us evaluate Sutro Biopharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.